A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients
NCT06021860 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 96
Last updated 2023-09-28
Summary
This is a 2-part, 2 periods per part, open-label study with spironolactone oral suspension in pediatric patients with edema due to HF or hepatic cirrhosis. Both study parts will evaluate the safety, PK and PD of multiple doses of spironolactone in patients aged from birth to ≤17 years of age.
Conditions
- Edema Due to Heart Failure or Cirrhosis
Interventions
- DRUG
-
Spironolactone Oral Suspension
Spironolactone will be dosed on a mg/kg basis, with actual weight on Day 1 (pre-dose) determining the spironolactone suspension volume administered. Therefore, for a given patient, the dose administered on Day 1, based on the weight measured on Day 1, will be administered throughout their participation in the study. Spironolactone will be administered as a single dose in the single-dose periods (Group 4, Parts 1 and 2), and as QD dosing in the multiple-dose periods (Groups 1 to 4, Parts 1 and 2). The low and high doses to be administered during Part 2 of the study will be determined by the Safety Review Committee following their review of Part 1 data.
Sponsors & Collaborators
-
CMP Development, LLC
lead INDUSTRY
Principal Investigators
-
Gerald Sakowski · CMP Pharma
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-30
- Primary Completion
- 2025-03-31
- Completion
- 2025-03-31
- FDA Drug
- Yes
More Related Trials
-
Impact of the Administration of Fludrocortisone in Very Premature Infants
NCT03001089 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing the Feasibility of N-of-1 Trials in Children With Hypertension and Chronic Kidney Disease
NCT04591171 ·Status: COMPLETED ·Phase: NA
-
A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)
NCT05201144 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Midodrine in Refractory or Recurrent Ascites in Children With Cirrhosis.
NCT05084534 ·Status: WITHDRAWN ·Phase: NA
-
To Assess the Efficacy of Midodrine in Prevention of Cirrhosis Related Complications in Children Awaiting Liver Transplantation.
NCT05287100 ·Status: COMPLETED ·Phase: NA
-
Effects of Nesiritide in Pediatric Patients With Heart Failure
NCT00166010 ·Status: WITHDRAWN ·Phase: NA
-
Evaluating Precision of Therapy - Milrinone
NCT01841177 ·Status: COMPLETED ·Phase: PHASE2
-
Home Inotropic Therapy in Children
NCT00327899 ·Status: TERMINATED
-
Study of Adrenocorticotropic Hormone on Children With Frequent Relapse or Steroid-dependent Nephrotic Syndrome: a Prospective, Multicenter, Randomized,Open-label Clinical Trial.
NCT06079788 ·Status: RECRUITING ·Phase: PHASE3
-
Relationship of Brain Natriuretic Peptide (BNP) Levels to Cardiac Diagnosis, Operation Performed, Post-operative Course and Outcome
NCT00238810 ·Status: COMPLETED
-
Liothyronine in Children With Single Ventricle Congenital Cardiac Malformations Undergoing the Fontan Procedure
NCT00004828 ·Status: COMPLETED ·Phase: PHASE1
-
Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation
NCT00113698 ·Status: TERMINATED ·Phase: PHASE3
-
Clinical Utility of SUDOSCAN in the Pediatric Population
NCT02216201 ·Status: WITHDRAWN
-
Acetazolamide Trial in Normal Pressure Hydrocephalus
NCT04975269 ·Status: COMPLETED ·Phase: PHASE2
-
Steroid Treatment of Idiopathic Nephrotic Syndrome
NCT01386957 ·Status: COMPLETED
-
Recognition of Abnormal Pediatric Blood Pressures in Primary Care
NCT00130663 ·Status: COMPLETED ·Phase: NA
-
Randomized Clinical Trial: Expectant Management vs Laser Treatment of Monochorionic Twins With Severe Selective Intrauterine Growth Retardation and Absent or Reverse Diastolic Flow in the Umbilical Artery
NCT01177553 ·Status: COMPLETED ·Phase: NA
-
Nutritional Failure in Infants With Single Ventricle Congenital Heart Disease
NCT01821287 ·Status: COMPLETED
-
Pharmacokinetics of Post Operative Cefuroxime in Infants Undergoing Cardiac Surgery
NCT02850250 ·Status: WITHDRAWN
-
Association of Insulin Resistance and FGF21 on Cardiac Function in Pediatric Dilated Cardiomyopathy
NCT04222101 ·Status: TERMINATED ·Phase: NA
-
Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass
NCT04217421 ·Status: RECRUITING ·Phase: PHASE3
-
Serum Brain Natriuretic Peptide Levels and Pulmonary Hypertension in Pediatric Sickle Cell Patients
NCT01023451 ·Status: COMPLETED
-
Study of Intramyocardial Injection of Ventrix Bio Extracellular Matrix (VentriGel) to Assess the Safety and Feasibility in Pediatric Patients with Hypoplastic Left Heart Syndrome (HLHS)
NCT06461676 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study of LJPC-501 in Pediatric Patients With Hypotension
NCT03431077 ·Status: COMPLETED ·Phase: PHASE2
-
Salt Wasting, Hydro-sodium Balance and Fludrocortisone Requirement in Congenital Adrenal Hyperplasia
NCT03550261 ·Status: COMPLETED